Biosimulation Market, By Product & Services (Software and Services), By Delivery Model (Ownership and Subscription), By Application (Drug Discovery and Drug Development), and By Geography (EU, NA, APAC, LATAM, and MEA) Analysis, Size, Share, Trends, & Forecast from 2021-2027
REPORT HIGHLIGHT
The global biosimulation market was valued at USD 1.56 billion by 2019, growing with 16.2% CAGR during the forecast period, 2021-2027.
Biosimulation refers to the process of addition of materials in order to enhance the activity and growth of the indigenous microorganisms at a contaminated site. It stimulates the organisms that are capable of bioremediation by modifying the environment.
Market Dynamics
Significant growth in the biologics and biosimilars expected to drive the market growth for biosimulation in the forthcoming years. Further, the growth of biosimilars is mainly driven by the increasing pressure on countries to curtail healthcare expenditure. Other prominent factors include the cost-effectiveness of biosimilars, a rising number of clinical trials on account of an increasing number of chronic disease cases, and a rising number of off-patented drugs. Biosimulation proved to be a boon for the pharmaceutical companies for testing the toxicity and other important parameters for dug safety as well as its effectiveness on the disease. However, lack of standardization in terms of tools, language, and models in the industry may restrict the market growth during the forecast period.
Product & Services Takeaway
On the basis of product & services, the industry is bifurcated into software and services. Software segment accounted for the largest value share in 2019 and anticipated to continue its dominance over the forthcoming years. The flourishing growth of the segment is mainly due to the rising adoption of biosimulation software platform by pharmaceutical and biopharmaceutical companies. In addition, increasing investment in the research & development (R&D) sector for pharmaceutical research again boosts the market growth. As per the EvaluatePharma report published in the year 2018, worldwide spending in the pharmaceutical R&D surged by 3.9% to USD 165 Bn in 2017 compared to 2016. In 2017, the top 20 pharmaceutical companies spend an average of USD 100 Bn, with Roche maintaining its leading position in the R&D spending at USD 9.2 Bn.
Application Takeaway
In terms of application, the market is categorized into drug discovery, drug development, and others. Drug development accounted for a significant market share in 2019 owing to the increasing number of drug approvals in the recent past. For instance, the Food and Drug Administration (FDA) approvals for new molecular entities increased from 27 in the year 2016 to 55 & 59 in 2017 & 2018 respectively. Further, the dynamic in drug development spending expected to affect the statics in the coming years.
End-user Takeaway
In terms of end-user, the market is divided into regulatory authorities, pharmaceutical & biotechnology companies, contract research organizations, research institutes, and others. Pharmaceutical & biotechnology companies registered the highest value share in the industry for the year 2019 and predicted to grow at the highest rate in the coming years as well. An increasing budget of R&D spending by these companies accounted as the key factor behind their stimulus growth. For instance, F. Hoffmann-La Roche AG, one of the leading pharmaceutical company based in Switzerland, is one of the top spenders in pharma R&D and poised to remain at the leading position by 2024. Similarly, Johnson & Johnson and Celgene are the other prominent investors in pharma R&D.
Regional Takeaway
Geographically, the global industry classified into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global industry for biosimulation because of significant growth in the biopharmaceutical and pharmaceutical companies, increased demand for personalized medicines, and high investment in the drug development process in the region. Further, the region is the highest spender on pharmaceutical research activities that again accounts for the prominent market growth. For instance, the EvaluatePharma report 2018 states that more than half of the global R&D expenditure on pharmaceutical research spending by the United States pharma giants.
On the contrary, the Asia Pacific seeks to be the most opportunistic market in biosimulation owing to increasing spending in healthcare research. Further, a large population base for the testing of new drugs also creates an alluring opportunity for the pharma and biopharma companies in the region.
COVID-19 Impact
The COVID-19 outbreak has brought several disruptions in the healthcare industry. A sudden surge in the demand for personal protective equipment (PPE) kits, gloves, masks, and diagnostic procedures has flourishes market growth. However, specific treatment and equipment seek a steep decline in their demand that has led to the shut of manufacturing operations of several industry players. Biosimulation holds magnificent growth prospect in the COVID-19 situation as there is a sudden rise in the demand for new drug development and advancement to fight against the deadly virus.
Key Vendor Takeaway
Some of the prominent players operating in the industry include Simulations Plus, Certara, Schrödinger, Dassault Systèmes, Chemical Computing Group, ACD/Labs, In silico biosciences, Physiomics, Evidera, Insilico Biotechnology, Nuventra Pharma, INOSIM Software, and LeadInvent Technologies among others.
The industry witnessed a high rate of competition among the industry participants due to continuous demand for the product & services from the consumer side. Further, these industry players significantly adopt inorganic growth strategies such as partnership, collaboration, merger & acquisition, joint venture, and agreement to uplift their market position and retain their competitive edge. For instance, in April 2017, Simulations Plus entered into a distributor agreement with Quantum Bio Solutions of South Korea with the purpose of cementing its relation with South Korean companies.
Similarly, in June 2017, Simulations Plus signed an acquisition agreement with DILIsym Services, Inc. This initiative by the company helps to expand its product range in simulation software & consulting services for drug-originated liver injury.
The market size and forecast for each segment and sub-segments has been considered as below:
- Historical Year – 2016 to 2018
- Base Year – 2019
- Estimated Year – 2020
- Projected Year – 2021 to 2027
TARGET AUDIENCE
- Traders, Distributors, and Suppliers
- Manufacturers
- Government and Regional Agencies
- Research Organizations
- Consultants
- Distributors
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL BIOSIMULATION MARKET KEY PLAYERS
- Simulations Plus
- Certara
- Schrödinger
- Dassault Systèmes
- Chemical Computing Group
- ACD/Labs
- In silico biosciences
- Physiomics
- Evidera
- Insilico Biotechnology
- Nuventra Pharma
- INOSIM Software
- LeadInvent Technologies
GLOBAL BIOSIMULATION MARKET, BY PRODUCT & SERVICES
- Software
- Molecular Modeling and Simulation Software
- Toxicity Prediction Software
- PK/PD Modeling and Simulation Software
- PBPK Modeling and Simulation Software
- Trial Design Software
- Others
- Services
GLOBAL BIOSIMULATION MARKET, BY DELIVERY MODEL
- Ownership
- Subscription
GLOBAL BIOSIMULATION MARKET, BY APPLICATION
- Drug Discovery
- Lead Identification & Optimization
- Target Identification & Validation
- Drug Development
- Clinical Trials
- Preclinical Testing
- Others
GLOBAL BIOSIMULATION MARKET, BY END-USER
- Regulatory Authorities
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations
- Research Institutes
- Others
GLOBAL BIOSIMULATION MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Singapore
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Rest of MEA
TABLE OF CONTENT
1. BIOSIMULATION MARKET OVERVIEW
1.1. Study Scope
2. EXECUTIVE SUMMARY
2.1. Market Snippet
2.1.1. Market Snippet by Product & Services
2.1.2. Market Snippet by Delivery Model
2.1.3. Market Snippet by Application
2.1.4. Market Snippet by End-user
2.1.5. Market Snippet by Region
2.2. Competitive Insights
3. BIOSIMULATION KEY MARKET TRENDS
3.1. Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Market Opportunities
3.4. Market Future Trends
4. BIOSIMULATION INDUSTRY STUDY
4.1. Porter’s Five Forces Analysis
4.2. Marketing Strategy Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. BIOSIMULATION MARKET: COVID-19 IMPACT ANALYSIS
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. BIOSIMULATION MARKET LANDSCAPE
6.1. Market Share Analysis, 2019
6.2. Key Innovators Analysis
6.3. Breakdown Data, by Key Manufacturer
6.3.1. Established Players’ Analysis
6.3.2. Emerging Players’ Analysis
7. BIOSIMULATION MARKET – BY PRODUCT & SERVICES
7.1. Overview
7.1.1. Segment Share Analysis, By Product & Services, 2020 & 2027 (%)
7.2. Software
7.2.1. Overview
7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Billion)
7.2.3. Molecular Modeling and Simulation Software
7.2.4. Toxicity Prediction Software
7.2.5. PK/PD Modeling and Simulation Software
7.2.6. PBPK Modeling and Simulation Software
7.2.7. Trial Design Software
7.2.8. Others
7.3. Services
7.3.1. Overview
7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Billion)
8. BIOSIMULATION MARKET – BY DELIVERY MODEL
8.1. Overview
8.1.1. Segment Share Analysis, By Delivery Model, 2020 & 2027 (%)
8.2. Ownership
8.2.1. Overview
8.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Billion)
8.3. Subscription
8.3.1. Overview
8.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Billion)
9. BIOSIMULATION MARKET – BY APPLICATION
9.1. Overview
9.1.1. Segment Share Analysis, By Application, 2020 & 2027 (%)
9.2. Drug Discovery
9.2.1. Overview
9.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Billion)
9.2.3. Lead Identification & Optimization
9.2.4. Target Identification & Validation
9.3. Drug Development
9.3.1. Overview
9.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Billion)
9.3.3. Clinical Trials
9.3.4. Preclinical Testing
9.4. Others
9.4.1. Overview
9.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Billion)
10. BIOSIMULATION MARKET – BY END-USER
10.1. Overview
10.1.1. Segment Share Analysis, By End-user, 2020 & 2027 (%)
10.2. Regulatory Authorities
10.2.1. Overview
10.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Billion)
10.3. Pharmaceutical & Biotechnology Companies
10.3.1. Overview
10.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Billion)
10.4. Contract Research Organizations
10.4.1. Overview
10.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Billion)
10.5. Research Institutes
10.5.1. Overview
10.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Billion)
10.6. Others
10.6.1. Overview
10.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Billion)
11. BIOSIMULATION MARKET– BY GEOGRAPHY
11.1. Introduction
11.1.1. Segment Share Analysis, By Geography, 2020 & 2027 (%)
11.2. North America
11.2.1. Overview
11.2.2. Key Manufacturers in North America
11.2.3. North America Market Size and Forecast, By Country, 2016 – 2027 (US$ Billion)
11.2.4. North America Market Size and Forecast, By Product & Services, 2016 – 2027 (US$ Billion)
11.2.5. North America Market Size and Forecast, By Delivery Model, 2016 – 2027 (US$ Billion)
11.2.6. North America Market Size and Forecast, By Application, 2016 – 2027 (US$ Billion)
11.2.7. North America Market Size and Forecast, By End-user, 2016 – 2027 (US$ Billion)
11.2.8. U.S.
11.2.8.1. Overview
11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Billion)
11.2.8.3. U.S. Market Size and Forecast, By Product & Services, 2016 – 2027 (US$ Billion)
11.2.8.4. U.S. Market Size and Forecast, By Delivery Model, 2016 – 2027 (US$ Billion)
11.2.8.5. U.S. Market Size and Forecast, By Application, 2016 – 2027 (US$ Billion)
11.2.8.6. U.S. Market Size and Forecast, By End-user, 2016 – 2027 (US$ Billion)
11.2.9. Canada
11.2.9.1. Overview
11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Billion)
1.1.1.1. Canada Market Size and Forecast, By Product & Services, 2016 – 2027 (US$ Billion)
1.1.1.2. Canada Market Size and Forecast, By Delivery Model, 2016 – 2027 (US$ Billion)
1.1.1.3. Canada Market Size and Forecast, By Application, 2016 – 2027 (US$ Billion)
1.1.1.4. Canada Market Size and Forecast, By End-user, 2016 – 2027 (US$ Billion)
11.3. Europe
11.3.1. Overview
11.3.2. Key Manufacturers in Europe
11.3.3. Europe Market Size and Forecast, By Country, 2016 – 2027 (US$ Billion)
11.3.4. Europe Market Size and Forecast, By Product & Services, 2016 – 2027 (US$ Billion)
11.3.5. Europe Market Size and Forecast, By Delivery Model, 2016 – 2027 (US$ Billion)
11.3.6. Europe Market Size and Forecast, By Application, 2016 – 2027 (US$ Billion)
11.3.7. Europe Market Size and Forecast, By End-user, 2016 – 2027 (US$ Billion)
11.3.8. Germany
11.3.8.1. Overview
11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Billion)
11.3.8.3. Germany Market Size and Forecast, By Product & Services, 2016 – 2027 (US$ Billion)
11.3.8.4. Germany Market Size and Forecast, By Delivery Model, 2016 – 2027 (US$ Billion)
11.3.8.5. Germany Market Size and Forecast, By Application, 2016 – 2027 (US$ Billion)
11.3.8.6. Germany Market Size and Forecast, By End-user, 2016 – 2027 (US$ Billion)
11.3.9. Italy
11.3.9.1. Overview
11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Billion)
11.3.9.3. Italy Market Size and Forecast, By Product & Services, 2016 – 2027 (US$ Billion)
11.3.9.4. Italy Market Size and Forecast, By Delivery Model, 2016 – 2027 (US$ Billion)
11.3.9.5. Italy Market Size and Forecast, By Application, 2016 – 2027 (US$ Billion)
11.3.9.6. Italy Market Size and Forecast, By End-user, 2016 – 2027 (US$ Billion)
11.3.10. United Kingdom
11.3.10.1. Overview
11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Billion)
11.3.10.3. United Kingdom Market Size and Forecast, By Product & Services, 2016 – 2027 (US$ Billion)
11.3.10.4. United Kingdom Market Size and Forecast, By Delivery Model, 2016 – 2027 (US$ Billion)
11.3.10.5. United Kingdom Market Size and Forecast, By Application, 2016 – 2027 (US$ Billion)
11.3.10.6. United Kingdom Market Size and Forecast, By End-user, 2016 – 2027 (US$ Billion)
11.3.11. France
11.3.11.1. Overview
11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Billion)
11.3.11.3. France Market Size and Forecast, By Product & Services, 2016 – 2027 (US$ Billion)
11.3.11.4. France Market Size and Forecast, By Delivery Model, 2016 – 2027 (US$ Billion)
11.3.11.5. France Market Size and Forecast, By Application, 2016 – 2027 (US$ Billion)
11.3.11.6. France Market Size and Forecast, By End-user, 2016 – 2027 (US$ Billion)
11.3.12. Rest of Europe
11.3.12.1. Overview
11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Billion)
11.3.12.3. Rest of the Europe Market Size and Forecast, By Product & Services, 2016 – 2027 (US$ Billion)
11.3.12.4. Rest of the Europe Market Size and Forecast, By Delivery Model, 2016 – 2027 (US$ Billion)
11.3.12.5. Rest of the Europe Market Size and Forecast, By Application, 2016 – 2027 (US$ Billion)
11.3.12.6. Rest of the Europe Market Size and Forecast, By End-user, 2016 – 2027 (US$ Billion)
11.4. Asia Pacific (APAC)
11.4.1. Overview
11.4.2. Key Manufacturers in Asia Pacific
11.4.3. Asia Pacific Market Size and Forecast, By Country, 2016 – 2027 (US$ Billion)
11.4.4. Asia Pacific Market Size and Forecast, By Product & Services, 2016 – 2027 (US$ Billion)
11.4.5. Asia Pacific Market Size and Forecast, By Delivery Model, 2016 – 2027 (US$ Billion)
11.4.6. Asia Pacific Market Size and Forecast, By Application, 2016 – 2027 (US$ Billion)
11.4.7. Asia Pacific Market Size and Forecast, By End-user, 2016 – 2027 (US$ Billion)
11.4.8. India
11.4.8.1. Overview
11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Billion)
11.4.8.3. India Market Size and Forecast, By Product & Services, 2016 – 2027 (US$ Billion)
11.4.8.4. India Market Size and Forecast, By Delivery Model, 2016 – 2027 (US$ Billion)
11.4.8.5. India Market Size and Forecast, By Application, 2016 – 2027 (US$ Billion)
11.4.8.6. India Market Size and Forecast, By End-user, 2016 – 2027 (US$ Billion)
11.4.9. China
11.4.9.1. Overview
11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Billion)
11.4.9.3. China Market Size and Forecast, By Product & Services, 2016 – 2027 (US$ Billion)
11.4.9.4. China Market Size and Forecast, By Delivery Model, 2016 – 2027 (US$ Billion)
11.4.9.5. China Market Size and Forecast, By Application, 2016 – 2027 (US$ Billion)
11.4.9.6. China Market Size and Forecast, By End-user, 2016 – 2027 (US$ Billion)
11.4.10. Japan
11.4.10.1. Overview
11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Billion)
11.4.10.3. Japan Market Size and Forecast, By Product & Services, 2016 – 2027 (US$ Billion)
11.4.10.4. Japan Market Size and Forecast, By Delivery Model, 2016 – 2027 (US$ Billion)
11.4.10.5. Japan Market Size and Forecast, By Application, 2016 – 2027 (US$ Billion)
11.4.10.6. Japan Market Size and Forecast, By End-user, 2016 – 2027 (US$ Billion)
11.4.11. South Korea
11.4.11.1. Overview
11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Billion)
11.4.11.3. South Korea Market Size and Forecast, By Product & Services, 2016 – 2027 (US$ Billion)
11.4.11.4. South Korea Market Size and Forecast, By Delivery Model, 2016 – 2027 (US$ Billion)
11.4.11.5. South Korea Market Size and Forecast, By Application, 2016 – 2027 (US$ Billion)
11.4.11.6. South Korea Market Size and Forecast, By End-user, 2016 – 2027 (US$ Billion)
11.4.12. Rest of APAC
11.4.12.1. Overview
11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Billion)
11.4.12.3. Rest of APAC Market Size and Forecast, By Product & Services, 2016 – 2027 (US$ Billion)
11.4.12.4. South Korea Market Size and Forecast, By Delivery Model, 2016 – 2027 (US$ Billion)
11.4.12.5. Rest of APAC Market Size and Forecast, By Application, 2016 – 2027 (US$ Billion)
11.4.12.6. Rest of APAC Market Size and Forecast, By End-user, 2016 – 2027 (US$ Billion)
11.5. Latin America
11.5.1. Overview
11.5.2. Key Manufacturers in Latin America
11.5.3. Latin America Market Size and Forecast, By Country, 2016 – 2027 (US$ Billion)
11.5.4. Latin America Market Size and Forecast, By Product & Services, 2016 – 2027 (US$ Billion)
11.5.5. Latin America Market Size and Forecast, By Delivery Model, 2016 – 2027 (US$ Billion)
11.5.6. Latin America Market Size and Forecast, By Application, 2016 – 2027 (US$ Billion)
11.5.7. Latin America Market Size and Forecast, By End-user, 2016 – 2027 (US$ Billion)
11.5.8. Brazil
11.5.8.1. Overview
11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Billion)
11.5.8.3. Brazil Market Size and Forecast, By Product & Services, 2016 – 2027 (US$ Billion)
11.5.8.4. Brazil Market Size and Forecast, By Delivery Model, 2016 – 2027 (US$ Billion)
11.5.8.5. Brazil Market Size and Forecast, By Application, 2016 – 2027 (US$ Billion)
11.5.8.6. Brazil Market Size and Forecast, By End-user, 2016 – 2027 (US$ Billion)
11.5.9. Mexico
11.5.9.1. Overview
11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Billion)
11.5.9.3. Mexico Market Size and Forecast, By Product & Services, 2016 – 2027 (US$ Billion)
11.5.9.4. Mexico Market Size and Forecast, By Delivery Model, 2016 – 2027 (US$ Billion)
11.5.9.5. Mexico Market Size and Forecast, By Application, 2016 – 2027 (US$ Billion)
11.5.9.6. Mexico Market Size and Forecast, By End-user, 2016 – 2027 (US$ Billion)
11.5.10. Argentina
11.5.10.1. Overview
11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Billion)
11.5.10.3. Argentina Market Size and Forecast, By Product & Services, 2016 – 2027 (US$ Billion)
11.5.10.4. Argentina Market Size and Forecast, By Delivery Model, 2016 – 2027 (US$ Billion)
11.5.10.5. Argentina Market Size and Forecast, By Application, 2016 – 2027 (US$ Billion)
11.5.10.6. Argentina Market Size and Forecast, By End-user, 2016 – 2027 (US$ Billion)
11.5.11. Rest of LATAM
11.5.11.1. Overview
11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Billion)
11.5.11.3. Rest of LATAM Market Size and Forecast, By Product & Services, 2016 – 2027 (US$ Billion)
11.5.11.4. Rest of LATAM Market Size and Forecast, By Delivery Model, 2016 – 2027 (US$ Billion)
11.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2016 – 2027 (US$ Billion)
11.5.11.6. Rest of LATAM Market Size and Forecast, By End-user, 2016 – 2027 (US$ Billion)
11.6. Middle East and Africa
11.6.1. Overview
11.6.2. Key Manufacturers in Middle East and Africa
11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2016 – 2027 (US$ Billion)
11.6.4. Middle East and Africa Market Size and Forecast, By Product & Services, 2016 – 2027 (US$ Billion)
11.6.5. Middle East and Africa Market Size and Forecast, By Delivery Model, 2016 – 2027 (US$ Billion)
11.6.6. Middle East and Africa Market Size and Forecast, By Application, 2016 – 2027 (US$ Billion)
11.6.7. Middle East and Africa Market Size and Forecast, By End-user, 2016 – 2027 (US$ Billion)
11.6.8. Saudi Arabia
11.6.8.1. Overview
11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Billion)
11.6.8.3. Saudi Arabia Market Size and Forecast, By Product & Services, 2016 – 2027 (US$ Billion)
11.6.8.4. Saudi Arabia Market Size and Forecast, By Delivery Model, 2016 – 2027 (US$ Billion)
11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2016 – 2027 (US$ Billion)
11.6.8.6. Saudi Arabia Market Size and Forecast, By End-user, 2016 – 2027 (US$ Billion)
11.6.9. United Arab Emirates
11.6.9.1. Overview
11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Billion)
11.6.9.3. United Arab Emirates Market Size and Forecast, By Product & Services, 2016 – 2027 (US$ Billion)
11.6.9.4. United Arab Emirates Market Size and Forecast, By Delivery Model, 2016 – 2027 (US$ Billion)
11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2016 – 2027 (US$ Billion)
11.6.9.6. United Arab Emirates Market Size and Forecast, By End-user, 2016 – 2027 (US$ Billion)
12. KEY VENDOR ANALYSIS
12.1. Competitive Dashboard
12.2. Company Profiles
12.2.1. Simulations Plus
12.2.1.1. Company Snapshot
12.2.1.2. Financial Performance
12.2.1.3. Product & Services Benchmarking
12.2.1.4. Strategic Initiatives
12.2.2. Certara
12.2.3. Schrödinger
12.2.4. Dassault Systèmes
12.2.5. Chemical Computing Group
12.2.6. ACD/Labs
12.2.7. In silico biosciences
12.2.8. Physiomics
12.2.9. Evidera
12.2.10. Insilico Biotechnology
12.2.11. Nuventra Pharma
12.2.12. INOSIM Software
12.2.13. LeadInvent Technologies
13. 360 DEGREE ANALYSTVIEW
14. APPENDIX
14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us
List of Tables
TABLE List of data sources
TABLE Market drivers; Impact Analysis
TABLE Market restraints; Impact Analysis
TABLE Biosimulation market: Product & Services Snapshot (2019)
TABLE Segment Dashboard; Definition and Scope, by Product & Services
TABLE Global Biosimulation market, by Product & Services 2016-2027 (USD Billion)
TABLE Biosimulation market: Delivery Model Snapshot (2019)
TABLE Segment Dashboard; Definition and Scope, by Delivery Model
TABLE Global Biosimulation market, by Delivery Model 2016-2027 (USD Billion)
TABLE Biosimulation market: Application Snapshot (2019)
TABLE Segment Dashboard; Definition and Scope, by Application
TABLE Global Biosimulation market, by Application 2016-2027 (USD Billion)
TABLE Biosimulation market: End-user Snapshot (2019)
TABLE Segment Dashboard; Definition and Scope, by End-user
TABLE Global Biosimulation market, by End-user 2016-2027 (USD Billion)
TABLE Biosimulation market: Regional snapshot (2019)
TABLE Segment Dashboard; Definition and Scope, by Region
TABLE Global Biosimulation market, by Region 2016-2027 (USD Billion)
TABLE North America Biosimulation market, by Country, 2016-2027 (USD Billion)
TABLE North America Biosimulation market, by Product & Services, 2016-2027 (USD Billion)
TABLE North America Biosimulation market, by Delivery Model, 2016-2027 (USD Billion)
TABLE North America Biosimulation market, by Application, 2016-2027 (USD Billion)
TABLE North America Biosimulation market, by End-user, 2016-2027 (USD Billion)
TABLE Europe Biosimulation market, by Country, 2016-2027 (USD Billion)
TABLE Europe Biosimulation market, by Product & Services, 2016-2027 (USD Billion)
TABLE Europe Biosimulation market, by Delivery Model, 2016-2027 (USD Billion)
TABLE Europe Biosimulation market, by Application, 2016-2027 (USD Billion)
TABLE Europe Biosimulation market, by End-user, 2016-2027 (USD Billion)
TABLE Asia Pacific Biosimulation market, by Country, 2016-2027 (USD Billion)
TABLE Asia Pacific Biosimulation market, by Product & Services, 2016-2027 (USD Billion)
TABLE Asia Pacific Biosimulation market, by Delivery Model, 2016-2027 (USD Billion)
TABLE Asia Pacific Biosimulation market, by Application, 2016-2027 (USD Billion)
TABLE Asia Pacific Biosimulation market, by End-user, 2016-2027 (USD Billion)
TABLE Latin America Biosimulation market, by Country, 2016-2027 (USD Billion)
TABLE Latin America Biosimulation market, by Product & Services, 2016-2027 (USD Billion)
TABLE Latin America Biosimulation market, by Delivery Model, 2016-2027 (USD Billion)
TABLE Latin America Biosimulation market, by Application, 2016-2027 (USD Billion)
TABLE Latin America Biosimulation market, by End-user, 2016-2027 (USD Billion)
TABLE Middle East and Africa Biosimulation market, by Country, 2016-2027 (USD Billion)
TABLE Middle East and Africa Biosimulation market, by Product & Services, 2016-2027 (USD Billion)
TABLE Middle East and Africa Biosimulation market, by Delivery Model, 2016-2027 (USD Billion)
TABLE Middle East and Africa Biosimulation market, by Application, 2016-2027 (USD Billion)
TABLE Middle East and Africa Biosimulation market, by End-user, 2016-2027 (USD Billion)
List of Figures
FIGURE Biosimulation market segmentation
FIGURE Market research methodology
FIGURE Value chain analysis
FIGURE Porter’s Five Forces Analysis
FIGURE Market Attractiveness Analysis
FIGURE COVID-19 Impact Analysis
FIGURE Pre & Post COVID-19 Impact Comparision Study
FIGURE Competitive Landscape; Key company market share analysis, 2019
FIGURE Product & Services segment market share analysis, 2020 & 2027
FIGURE Product & Services segment market size forecast and trend analysis, 2016 to 2027 (USD Billion)
FIGURE Software market size forecast and trend analysis, 2016 to 2027 (USD Billion)
FIGURE Services market size forecast and trend analysis, 2016 to 2027 (USD Billion)
FIGURE Delivery Model segment market share analysis, 2020 & 2027
FIGURE Delivery Model segment market size forecast and trend analysis, 2016 to 2027 (USD Billion)
FIGURE Ownership market size forecast and trend analysis, 2016 to 2027 (USD Billion)
FIGURE Subscription market size forecast and trend analysis, 2016 to 2027 (USD Billion)
FIGURE Application segment market share analysis, 2020 & 2027
FIGURE Application segment market size forecast and trend analysis, 2016 to 2027 (USD Billion)
FIGURE Drug Discovery market size forecast and trend analysis, 2016 to 2027 (USD Billion)
FIGURE Drug Development market size forecast and trend analysis, 2016 to 2027 (USD Billion)
FIGURE Others market size forecast and trend analysis, 2016 to 2027 (USD Billion)
FIGURE End-user segment market share analysis, 2020 & 2027
FIGURE End-user segment market size forecast and trend analysis, 2016 to 2027 (USD Billion)
FIGURE Regulatory Authorities market size forecast and trend analysis, 2016 to 2027 (USD Billion)
FIGURE Pharmaceutical & Biotechnology Companies market size forecast and trend analysis, 2016 to 2027 (USD Billion)
FIGURE Contract Research Organizations market size forecast and trend analysis, 2016 to 2027 (USD Billion)
FIGURE Research Institutes market size forecast and trend analysis, 2016 to 2027 (USD Billion)
FIGURE Others market size forecast and trend analysis, 2016 to 2027 (USD Billion)
FIGURE Regional segment market share analysis, 2020 & 2027
FIGURE Regional segment market size forecast and trend analysis, 2016 to 2027 (USD Billion)
FIGURE North America Biosimulation market share and leading players, 2019
FIGURE Europe Biosimulation market share and leading players, 2019
FIGURE Asia Pacific Biosimulation market share and leading players, 2019
FIGURE Latin America Biosimulation market share and leading players, 2019
FIGURE Middle East and Africa Biosimulation market share and leading players, 2019
FIGURE North America market share analysis by country, 2019
FIGURE U.S. Biosimulation market size, forecast and trend analysis, 2016 to 2027 (USD Billion)
FIGURE Canada Biosimulation market size, forecast and trend analysis, 2016 to 2027 (USD Billion)
FIGURE Europe Biosimulation market share analysis by country, 2019
FIGURE Germany Biosimulation market size, forecast and trend analysis, 2016 to 2027 (USD Billion)
FIGURE Spain Biosimulation market size, forecast and trend analysis, 2016 to 2027 (USD Billion)
FIGURE Italy Biosimulation market size, forecast and trend analysis, 2016 to 2027 (USD Billion)
FIGURE UK Biosimulation market size, forecast and trend analysis, 2016 to 2027 (USD Billion)
FIGURE France Biosimulation market size, forecast and trend analysis, 2016 to 2027 (USD Billion)
FIGURE Rest of the Europe Biosimulation market size, forecast and trend analysis, 2016 to 2027 (USD Billion)
FIGURE Asia Pacific Biosimulation market share analysis by country, 2019
FIGURE India Biosimulation market size, forecast and trend analysis, 2016 to 2027 (USD Billion)
FIGURE China Biosimulation market size, forecast and trend analysis, 2016 to 2027 (USD Billion)
FIGURE Japan Biosimulation market size, forecast and trend analysis, 2016 to 2027 (USD Billion)
FIGURE South Korea Biosimulation market size, forecast and trend analysis, 2016 to 2027 (USD Billion)
FIGURE Singapore Biosimulation market size, forecast and trend analysis, 2016 to 2027 (USD Billion)
FIGURE Rest of APAC Biosimulation market size, forecast and trend analysis, 2016 to 2027 (USD Billion)
FIGURE Latin America Biosimulation market size, forecast and trend analysis, 2016 to 2027 (USD Billion)
FIGURE Latin America Biosimulation market share analysis by country, 2019
FIGURE Brazil Biosimulation market size, forecast and trend analysis, 2016 to 2027 (USD Billion)
FIGURE Mexico Biosimulation market size, forecast and trend analysis, 2016 to 2027 (USD Billion)
FIGURE Argentina Biosimulation market size, forecast and trend analysis, 2016 to 2027 (USD Billion)
FIGURE Rest of LATAM Biosimulation market size, forecast and trend analysis, 2016 to 2027 (USD Billion)
FIGURE Middle East and Africa Biosimulation market size, forecast and trend analysis, 2016 to 2027 (USD Billion)
FIGURE Middle East and Africa Biosimulation market share analysis by country, 2019
FIGURE Saudi Arabia Biosimulation market size, forecast and trend analysis, 2016 to 2027 (USD Billion)
FIGURE United Arab Emirates Biosimulation market size, forecast and trend analysis, 2016 to 2027 (USD Billion)
